跳至主要内容
临床试验/CTRI/2021/07/035304
CTRI/2021/07/035304已完成2 期

A CLINICAL EVALUATION OF SIDDHA FORMULATION ââ?¬Å?KANDANGAARI NEIââ?¬? IN THE MANAGEMENT OF ââ?¬Å?SWASAKAASAMââ?¬?(BRONCHIAL ASTHMA).

ATIONAL INSTITUTE OF SIDDHA0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Age between 18-60 years.
  • Sex: Male, Female & Transgender.Patients with a clinical symptoms of Sneezing, Rhinitis, Dyspnoea, Cough with or without expectoration, Wheeze, Tightness of chest.
  • Wheezing more than 3 weeks.
  • Night time wheezing more than one day/week.
  • Asthma sometimes interferes with normal daily activities.
  • Status asthmaticus
  • Patients who are willing to take radiological investigation and provide blood for lab investigation.
  • Patients who are willing to estimate volume of air forcibly expired after a deep inspiration by using PFT.

排除标准

  • Tuberculosis
  • Restrictive lung disease
  • Pleural effusion
  • Cardiac disease
  • Renal disease
  • Diabetic mellitus
  • Symptoms of acute severe illness like Chest pain, nausea, vomiting, high fever, dyspnea
  • Recent haemoptysis
  • Pneumothorax
  • Recent history of abdominal, thoracic, or cerebral aneurysm
  • Sleep apnoea

研究者

相似试验